PUREMEDICAL ApS: Financial statements 2025
CVR: 31278996
Source: annual report 2025, Danish Business Authority
01/07/2024 – 30/06/2025
PUREMEDICAL ApS (CVR 31278996) has filed annual accounts for 2025. In 2025, the company reported a gross profit of DKK 819,115 and a net result of DKK 819,115 compared with DKK 484,264 the year before. Equity in the 2025 report amounted to DKK 2,541,908. The solvency ratio was 99.2%.
- Gross Profit
- DKK 819,115
- Profit/Loss
- DKK 819,115
- Equity
- DKK 2,541,908
- Total Assets
- DKK 2,563,148
- Employees
- 0
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2025 | - | 819K | 819K | 2.5M | 0 |
| 2024 | - | -4K | 484K | 1.7M | 0 |
| 2023 | - | -4K | 192K | 1.3M | 0 |
| 2022 | - | -4K | 437K | 968K | 0 |
| 2021 | - | -4K | 533K | 531K | 0 |
Official annual report
How creditworthy is PUREMEDICAL ApS?
See the CDS score and get a full credit report with recommended credit limit and payment terms.
Read about the CDS scoreAbout PUREMEDICAL ApS
PUREMEDICAL ApS is a Danish company of the type Anpartsselskab based in Roskilde, founded in 2008. The company is registered under the industry Ikke-finansielle holdingselskaber. The company was previously named BOAS PLUS ApS and THOMAS BOAS HOLDING ApS. The management consists of Thomas Boas. The company is owned by Thomas Boas. According to the 2026 annual report, the company had an average of 0 employees. In 2026, the company reported a gross profit of DKK 470,908 and a net result of DKK 620,918 compared with DKK 819,115 the year before. Equity in the 2026 report amounted to DKK 2,827,747.
